Nicotine Lozenge
Product Images NDC 58602-836

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nicotine (NDC 58602-836). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurohealth Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Nicotine Fig1)

Figure1 (Nicotine Fig1)
This is a reminder to place certain events on your calendar to begin quitting smoking. The reminders should be placed at the beginning of week 1 and week 7, and involve the use of lozenges every 1 to 2 hours in the first week and every 2 to 4 hours in the seventh week. There is also a reminder to mark the beginning of week 10 and 12 weeks after the quit date.*
FDA Label Image

Figure2 (Nicotine Fig2)

Figure2 (Nicotine Fig2)
This appears to be a wallet card containing a list of helpful resources to support an individual in quitting smoking. It includes the phone numbers for organizations such as the American Lung Association, American Cancer Society, and American Heart Association, as well as the suggestion to seek support from a quitting buddy or friend who has successfully quit smoking. The card also includes the alphanumeric code "P1530140".*
FDA Label Image

Package Label.principal Display Panel-4 mg (24 Lozenges, Container Label) (Nicotine Fig3)

Package Label.principal Display Panel-4 mg (24 Lozenges, Container Label) (Nicotine Fig3)
This is a description of a stop-smoking aid in the form of a mint-flavored lozenge containing Nicotine Polacrilex, marketed under the brand name "Pacer Lozenges". The product comes in a box containing 24 lozenges, with instructions for use stated on the box. The recommended usage varies with time, with one lozenge every two hours for the first six weeks, one lozenge every four hours for weeks seven to nine, and one lozenge every six to eight hours for weeks 10 to 12. The directions state that the lozenge should be placed in the mouth and allowed to dissolve, without being chewed or swallowed. The user should avoid eating or drinking for 15 minutes before and while the lozenge is in use. The maximum recommended usage is five lozenges in six hours, and twenty lozenges per day, and the lozenges should be kept away from children and pets. The package includes a warning against overdose and instructions on the safe disposal of used lozenges. The manufacturer, pulltiyr yt, is based in East Windsor, New Jersey, and the product is made in India.*
FDA Label Image

Package Label.principal Display Panel- 4 mg (24 Lozenges, Container Carton Label) (Nicotine Fig4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.